565176-62-7

Basic information

• Product Name: Benzaldehyde, 2-bromo-3-(methoxymethoxy)-
• CAS NO: 565176-62-7
• Molecular Formula: C9H9BrO3
• Molecular Weight: 245.073
• Mol File: 565176-62-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 2-bromo-3-(methoxymethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 2-bromo-3-(methoxymethoxy)-(565176-62-7)
• EPA Substance Registry System: Benzaldehyde, 2-bromo-3-(methoxymethoxy)-(565176-62-7)

Safety Data

• Hazardous Substances Data: 565176-62-7(Hazardous Substances Data)

Upstream product

• 196081-71-7 2-bromo-3-hydroxy-benzaldehyde 
• 107-30-2 chloromethyl methyl ether 
• 81245-32-1 (3-(methoxymethoxy)phenyl)methanol 
• 81245-42-3 methyl 3-{[(methyloxy)methyl]oxy}benzoate 
• 19438-10-9 methyl 3-hydroxybenzoate 
• 872123-31-4 (2-bromo-3-(methoxymethoxy)phenyl)methanol 
• 13709-05-2 3-methoxymethoxybenzaldehyde 

Downstream Products

• 888712-65-0 (R)-2-oxo-2-phenyl-benzo[c][1,2]thiazin-8-ol 
• 888712-78-5 (R)-8-(methoxymethoxy)-2-S-oxa-2-S-phenyl-2,1-benzothiazine 

Relevant articles and documents

Giving a Second Chance to Ir/Sulfoximine-Based Catalysts for the Asymmetric Hydrogenation of Olefins Containing Poorly Coordinative Groups

This work identifies a family of Ir/phosphite-sulfoximine catalysts that has been successfully used in the asymmetric hydrogenation of olefins with poorly coordinative or noncoordinative groups. In comparison with analogue Ir/phosphine-sulfoximine catalysts previously reported, the presence of a phosphite group extended the range of olefins than can be efficiently hydrogenated. High enantioselectivities, comparable to the best ones reported, have been achieved for a wide range of olefins containing relevant poorly coordinative groups such as α,β-unsaturated enones, esters, lactones, and lactams as well as alkenylboronic esters.

Studies towards the total synthesis of mumbaistatin: Synthesis of highly substituted benzophenone and anthraquinone building blocks

Model compounds and building blocks for a planned total synthesis of the highly potent glucose-6-phosphate (G6P) translocase inhibitor mumbaistatin (1) and structural analogs were elaborated: compound 1 represents a lead structure in the development of po